ReachMD CME-logo

ReachMD CME

ReachMD

Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, cardiology, women's health and more. And our CME library is continuously growing, every quarter.

Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, cardiology, women's health and more. And our CME library is continuously growing, every quarter.

Location:

Fort Washington, PA

Networks:

ReachMD

Description:

Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, cardiology, women's health and more. And our CME library is continuously growing, every quarter.

Language:

English


Episodes

Treatment of Vaginal Discharge Syndromes in Community Practice Settings

5/28/2020
CME credits: 0.25 Valid until: 28-05-2021 Claim your CME credit at https://reachmd.com/programs/cme/treatment-vaginal-discharge-syndromes-community-practice-settings/11562/ Vaginal infections are among the most common reasons why women in the United States seek medical care. These infections are typically characterized by discharge, itching, or odor. Although vaginal discharge symptoms are common, diagnosis of bacterial vaginosis (BV), vulvovaginal candidiasis (VVC), and Trichomonas...

Duration:00:12:59

Management of the Patient with Hepatitis B

5/27/2020
CME credits: 0.25 Valid until: 27-05-2021 Claim your CME credit at https://reachmd.com/programs/cme/management-patient-hepatitis-b/11564/ Chronic hepatitis B (CHB) is a serious viral disease associated with significant and preventable morbidity and mortality. There are an estimated 850,000-2.2 million persons living with CHB. Left untreated, up to 40% of those with CHB develop significant clinical consequences, including cirrhosis, liver failure, or HCC, and approximately 15% to 25% die...

Duration:00:17:59

Applying Real-World Evidence to Improve Clinical Decision-Making for Patients with HR-positive/HER2-negative Metastatic Breast Cancer

5/20/2020
CME credits: 0.25 Valid until: 19-05-2021 Claim your CME credit at https://reachmd.com/programs/cme/applying-real-world-evidence-improve-clinical-decision-making-patients-hr-positiveher2-negative-meta/11530/ Skepticism regarding the use of real-world evidence continues to exist among oncologists, but in actuality, real-world studies can provide information that may aid clinicians in Europe who are treating patients with HR-positive/HER2-negative metastatic breast cancer, especially...

Duration:00:14:59

Management of the Patient with Chronic Hepatitis C

5/1/2020
CME credits: 0.25 Valid until: 01-05-2021 Claim your CME credit at https://reachmd.com/programs/cme/management-patient-chronic-hepatitis-c/11443/ Chronic hepatitis C is a serious viral disease associated with significant and preventable morbidity and mortality, affecting an estimated 3.5 to 5 million patients. This activity will focus on improving the outcomes among patients with chronic hepatitis C by increasing awareness of its epidemiology, diagnosis and management, guidelines for...

Duration:00:17:29

The Changing Landscape of NSCLC: MET Inhibitors

4/30/2020
CME credits: 0.25 Valid until: 29-04-2021 Claim your CME credit at https://reachmd.com/programs/cme/the-changing-landscape-of-nsclc-met-inhibitors/11312/ Approximately 3 to 4 percent of the non-small cell lung cancer patient population as a whole harbors MET exon 14 skipping mutations that result in increased MET kinase protein levels and a constitutively active pathway. There is increasing excitement that these mutations, as well as MET gene amplification, can be specifically targeted...

Duration:00:14:59

Acquired Resistance to Targeted Therapy of NSCLC: A Global Perspective

4/30/2020
CME credits: 0.25 Valid until: 29-04-2021 Claim your CME credit at https://reachmd.com/programs/cme/acquired-resistance-to-targeted-therapy-of-nsclc-a-global-perspective/11313/ EGFR tyrosine kinase inhibitors, or EGFR-TKIs, have resulted in dramatic improvements for patients with EGFR-mutant advanced non-small cell lung cancer. However, acquired resistance continues to limit their long-term benefit. While often due to an acquired T790M mutation, dysregulation of the MET pathway in...

Duration:00:12:29

How to Approach Liquid Biopsy in the Treatment of NSCLC

4/30/2020
CME credits: 0.25 Valid until: 29-04-2021 Claim your CME credit at https://reachmd.com/programs/cme/how-approach-liquid-biopsy-treatment-nsclc/11275/ Learn insightful information around the treatment of non-small cell lung cancer (NSCLC) with thoughtful consideration of novel sampling applications, genomic mutations, and resistance mechanisms.

Duration:00:12:29

Emerging Treatment Considerations in Metastatic Urothelial Cancer

4/10/2020
CME credits: 0.25 Valid until: 10-04-2021 Claim your CME credit at https://reachmd.com/programs/cme/emerging-treatment-considerations-metastatic-urothelial-cancer/11388/ The treatment of urothelial carcinoma, the most common type of bladder cancer, has historically been limited to platinum-based chemotherapy; however, the majority of patients will relapse. And while immunotherapy has offered survival benefits to patients, not all patients respond to immune checkpoint inhibitors. That’s...

Duration:00:13:29

Precision Medicine in Advanced Prostate Cancer: A Focus on PARP Inhibitors

4/10/2020
CME credits: 0.50 Valid until: 09-04-2021 Claim your CME credit at https://reachmd.com/programs/cme/precision-medicine-advanced-prostate-cancer-focus-parp-inhibitors/11394/ The management of metastatic castration-resistant prostate cancer (mCRPC) remains clinically challenging due to limited therapeutic options, treatment-associated toxicities, primary or acquired resistance to systemic hormonal therapies, limited duration of response, and the high overall mortality rate. The significance...

Duration:00:35:59

Taking Care of Yourself While Taking Care of Others During COVID-19

4/10/2020
CME credits: 0.25 Valid until: 10-04-2021 Claim your CME credit at https://reachmd.com/programs/cme/taking-care-yourself-while-taking-care-others-during-covid-19/11406/ Due to the COVID-19 pandemic, healthcare providers are facing unprecedented stressors at work and at home that are taking a toll on their well-being. Join Dr. Nicole Washington, a board-certified psychiatrist who focuses on healthcare provider mental health, as she discusses different methods to cope with the fear,...

Duration:00:14:29

COVID-19: Interim Guidance on Management Pending Empirical Evidence. From an American Thoracic Society-led International Task Force

4/9/2020
CME credits: 0.25 Valid until: 09-04-2021 Claim your CME credit at https://reachmd.com/programs/cme/covid-19-interim-guidance-management-pending-empirical-evidence-american-thoracic-society/11408/ There is little empirical evidence to guide the management of COVID-19. However, with new cases being confirmed daily and the rate still increasing, clinicians taking care of patients with COVID-19 need guidance now. That’s why, with the support of the American Thoracic Society, an international...

Duration:00:13:29

Emerging Treatment Considerations in Metastatic Urothelial Cancer

4/7/2020
CME credits: 0.25 Valid until: 07-04-2021 Claim your CME credit at https://reachmd.com/cme/dental/emerging-treatment-considerations-metastatic-urothelial-cancer/11388/ The treatment of urothelial cancer has historically been limited to platinum-based chemotherapy; however, the majority of patients will relapse. And while immunotherapy has offered survival benefits to patients, not all patients respond to immune checkpoint inhibitors. That’s why it’s so important for clinicians to...

Duration:00:12:59

Telemedicine During COVID-19 Outbreak

4/7/2020
CME credits: 0.25 Valid until: 07-04-2021 Claim your CME credit at https://reachmd.com/programs/cme/telemedicine-during-covid-19-outbreak/11393/ Tune in as Drs. Suneet Mittal from the Valley Health System in New Jersey and Aysha Arshad from Carient Heart and Vascular in Virginia discuss how telemedicine has been utilized in their practices during the COVID-19 pandemic and how you can make telemedicine work in your own practice.

Duration:00:14:29

How Primary Care Clinicians on the Frontline Are Managing Patients During the COVID-19 Pandemic

4/6/2020
CME credits: 0.25 Valid until: 06-04-2021 Claim your CME credit at https://reachmd.com/programs/cme/how-primary-care-clinicians-frontline-are-managing-patients-during-covid-19-pandemic/11395/ Outpatient, community-based primary care practices are being impacted in a variety of ways by the COVID-19 pandemic. Join Drs. Jennifer Caudle and Brian McDonough as they explore various methods they’ve used to maintain connections with their patients and fellow peers, what lessons they’ve learned...

Duration:00:14:59

COVID-19 & Cardiovascular Considerations

4/4/2020
CME credits: 0.25 Valid until: 04-04-2021 Claim your CME credit at https://reachmd.com/programs/cme/covid-19-cardiovascular-considerations/11392/ Tune in as Drs. C. Michael Gibson and Deepak Bhatt from the Harvard Medical School discuss their experiences managing patients with cardiovascular disease during the COVID-19 pandemic along with the evidence that’s been accumulated about the interplay between COVID-19 and cardiovascular disease.

Duration:00:17:59

New Ulcerative Colitis Paradigms in the Personalized Pursuit of Remission

3/31/2020
CME credits: 0.25 Valid until: 31-03-2021 Claim your CME credit at https://reachmd.com/programs/cme/new-ulcerative-colitis-paradigms-in-the-personalized-pursuit-of-remission/11317/ Here to review new and emerging biomarkers that offer the potential to personalize therapy in ulcerative colitis are Drs. David Rubin and Christina Ha. Together, they’ll discuss the efficacy and safety of newer therapies and mechanisms of action in comparison to currently available treatment options.

Duration:00:16:30

Emerging Science in the Personalized Pursuit of Remission in Ulcerative Colitis Patients

3/31/2020
CME credits: 0.25 Valid until: 31-03-2021 Claim your CME credit at https://reachmd.com/programs/cme/emerging-science-personalized-pursuit-remission-ulcerative-colitis-patients/11316/ Join Dr. David Rubin and Dr. Christina Ha as they review new investigational mechanisms of action that offer the potential to optimize and maintain remission, as well as overcome the challenges of primary and secondary non-response seen with current therapies used in the management of ulcerative colitis.

Duration:00:16:30

Evidence and Value of Prescription Omega-3 Fatty Acids in Cardiovascular Disease Management

3/31/2020
CME credits: 0.25 Valid until: 31-03-2021 Claim your CME credit at https://reachmd.com/programs/cme/evidence-and-value-of-prescription-omega-3-fatty-acids-in-cardiovascular-disease-management/11291/ Despite the success of statin therapy in significantly reducing patients’ LDL-cholesterol and the risk of cardiovascular events, there remains a considerable need for event reduction. Fortunately, we now have findings from the REDUCE-IT landmark trial on icosapent ethyl that could help us find...

Duration:00:15:59

What You Need to Know About Neuromodulators

3/31/2020
CME credits: 0.25 Valid until: 31-03-2021 Claim your CME credit at https://reachmd.com/programs/cme/what-you-need-to-know-about-neuromodulators/11360/ Cosmetic use of botulinum neurotoxin has grown significantly over the past two decades, with four products now approved for use in the US. However, there are important differences amongst these products, and their use is not interchangeable, making it essential that clinicians understand their differences and the appropriate use of each...

Duration:00:15:59

Severe Asthma and Related Eosinophilic Diseases: The Role of IL-5 in Diagnosis and Treatment

3/31/2020
CME credits: 0.75 Valid until: 30-03-2021 Claim your CME credit at https://reachmd.com/programs/cme/severe-asthma-and-related-eosinophilic-diseases-the-role-of-il-5-in-diagnosis-and-treatment/11302/ This 45-minute enduring activity (three 15 minute chapters) covers the role of eosinophils and type 2 inflammation in severe asthma and eosinophil-related diseases. Understanding how to identify the mechanisms of action for biologic therapies can aid providers in selecting appropriate...

Duration:00:43:59